BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 234 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $300,130 | -8.8% | 42,632 | +8.0% | 0.00% | -100.0% |
| Q1 2023 | $329,255 | -30.3% | 39,479 | -4.0% | 0.00% | 0.0% |
| Q4 2022 | $472,207 | -8.8% | 41,133 | -0.1% | 0.00% | 0.0% |
| Q3 2022 | $518,000 | +16.9% | 41,155 | -1.8% | 0.00% | 0.0% |
| Q2 2022 | $443,000 | -35.8% | 41,903 | -1.2% | 0.00% | 0.0% |
| Q1 2022 | $690,000 | +9.7% | 42,421 | -6.7% | 0.00% | 0.0% |
| Q4 2021 | $629,000 | -69.4% | 45,446 | -77.2% | 0.00% | -80.0% |
| Q4 2015 | $2,055,000 | -9.5% | 199,100 | 0.0% | 0.01% | 0.0% |
| Q3 2015 | $2,270,000 | -23.6% | 199,100 | 0.0% | 0.01% | -16.7% |
| Q2 2015 | $2,973,000 | +63.6% | 199,100 | -1.1% | 0.01% | +50.0% |
| Q1 2015 | $1,817,000 | – | 201,230 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 1,105,673 | $8,237,000 | 6.28% |
| Sarissa Capital Management LP | 8,175,000 | $60,903,000 | 6.22% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,980,870 | $22,207,000 | 2.78% |
| DG Capital Management, LLC | 1,075,732 | $8,014,000 | 1.70% |
| Ghost Tree Capital, LLC | 900,000 | $6,705,000 | 1.49% |
| Parkman Healthcare Partners LLC | 538,370 | $4,011,000 | 1.03% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,835,810 | $43,477,000 | 0.86% |
| Formidable Asset Management, LLC | 470,419 | $3,470,000 | 0.80% |
| KNOTT DAVID M | 219,461 | $1,635,000 | 0.74% |
| Altium Capital Management LP | 250,000 | $1,863,000 | 0.70% |